Articles by Disease (Non-melanoma Skin Cancer)

Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications

Journal: Current Pharmaceutical Design
Volume: 13
Page: 933-962
Author(s): C. Alarcon de la Lastra, I. Villegas and S. Sanchez-Fidalgo

Design of New Oxazaphosphorine Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 13
Page: 963-978
Author(s): Jun Liang, Min Huang, Wei Duan, Xue-Qing Yu and Shufeng Zhou

CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7
Page: 253-273
Author(s): Michael A. Thompson, Kei Ohnuma, Masako Abe, Chikao Morimoto and Nam H. Dang

Prolyl Peptidases Related to Dipeptidyl Peptidase IV: Potential of Specific Inhibitors in Drug Discovery.

Journal: Current Topics in Medicinal Chemistry
Volume: 7
Page: 621-635
Author(s): Pieter Van der Veken, Achiel Haemers and Koen Augustyns

Electrotransfer as a Non Viral Method of Gene Delivery

Journal: Current Gene Therapy
Volume: 7
Page: 67-77
Author(s): Cyril Favard, David S. Dean and Marie-Pierre Rols

Recent Developments in Tumor Angiogenesis

Journal: Current Pharmaceutical Biotechnology
Volume: 8
Page: 3-9
Author(s): W. W. Kilarski and A. Bikfalvi

Drug Resistance in Melanoma: New Perspectives

Journal: Current Medicinal Chemistry
Volume: 14
Page: 387-391
Author(s): Caterina A.M. La Porta

Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases

Journal: Current Drug Targets
Volume: 8
Page: 217-235
Author(s): M. A. Morgan, A. Ganser and C. W. M. Reuter

Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target

Journal: Current Cancer Therapy Reviews
Volume: 3
Page: 1-6
Author(s): Virna D. Leaner, Howard Donninger and Michael J. Birrer

Cellular Senescence as a Target in Cancer Control

Journal: Current Cancer Therapy Reviews
Volume: 3
Page: 7-15
Author(s): Amancio Carnero